cation exchange cm10 array Search Results


95
GE Healthcare source 15s cation exchange column
Source 15s Cation Exchange Column, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/source 15s cation exchange column/product/GE Healthcare
Average 95 stars, based on 1 article reviews
source 15s cation exchange column - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

93
Bio-Rad weak cation exchange cm10 proteinchip arrays
Weak Cation Exchange Cm10 Proteinchip Arrays, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/weak cation exchange cm10 proteinchip arrays/product/Bio-Rad
Average 93 stars, based on 1 article reviews
weak cation exchange cm10 proteinchip arrays - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

90
Ciphergen inc cm10 proteinchip arrays (weak cationic exchange capacity)
Cm10 Proteinchip Arrays (Weak Cationic Exchange Capacity), supplied by Ciphergen inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cm10 proteinchip arrays (weak cationic exchange capacity)/product/Ciphergen inc
Average 90 stars, based on 1 article reviews
cm10 proteinchip arrays (weak cationic exchange capacity) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

94
Bio-Rad cation exchange chromatographic surface
Cation Exchange Chromatographic Surface, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cation exchange chromatographic surface/product/Bio-Rad
Average 94 stars, based on 1 article reviews
cation exchange chromatographic surface - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

86
Philips Healthcare cm10 microscope
Cm10 Microscope, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cm10 microscope/product/Philips Healthcare
Average 86 stars, based on 1 article reviews
cm10 microscope - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Difco tsb cm10
Tsb Cm10, supplied by Difco, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tsb cm10/product/Difco
Average 86 stars, based on 1 article reviews
tsb cm10 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

90
GenScript corporation cm10 sequence lianak
List of experimental groups and concentrations evaluated.
Cm10 Sequence Lianak, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cm10 sequence lianak/product/GenScript corporation
Average 90 stars, based on 1 article reviews
cm10 sequence lianak - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Spectronics corporation fluorescence analysis cabinet model cm–10
List of experimental groups and concentrations evaluated.
Fluorescence Analysis Cabinet Model Cm–10, supplied by Spectronics corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescence analysis cabinet model cm–10/product/Spectronics corporation
Average 90 stars, based on 1 article reviews
fluorescence analysis cabinet model cm–10 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

86
Hu-Friedy Manufacturing Co Inc cm10 miller de surgical curette
List of experimental groups and concentrations evaluated.
Cm10 Miller De Surgical Curette, supplied by Hu-Friedy Manufacturing Co Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cm10 miller de surgical curette/product/Hu-Friedy Manufacturing Co Inc
Average 86 stars, based on 1 article reviews
cm10 miller de surgical curette - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc cryostor cm10
List of experimental groups and concentrations evaluated.
Cryostor Cm10, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cryostor cm10/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
cryostor cm10 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
TriNetX Inc icd-10-cm
List of experimental groups and concentrations evaluated.
Icd 10 Cm, supplied by TriNetX Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/icd-10-cm/product/TriNetX Inc
Average 90 stars, based on 1 article reviews
icd-10-cm - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

86
Philips Healthcare sem edx philips cm 10 analyzers
List of experimental groups and concentrations evaluated.
Sem Edx Philips Cm 10 Analyzers, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sem edx philips cm 10 analyzers/product/Philips Healthcare
Average 86 stars, based on 1 article reviews
sem edx philips cm 10 analyzers - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


List of experimental groups and concentrations evaluated.

Journal: Osteoarthritis and Cartilage Open

Article Title: Comparison of multiple synthetic chondroinductive factors in pellet culture against a TGF-β positive control

doi: 10.1016/j.ocarto.2023.100369

Figure Lengend Snippet: List of experimental groups and concentrations evaluated.

Article Snippet: For experimental groups, KGN (Cat# HY-16268, MedChemExpress, Monmouth Junction, NJ), SM04690 (Cat# HY-109049, MedChemExpress, Monmouth Junction, NJ), CM10 (Sequence LIANAK, Genscript, New Jersey), and/or CK2.1 (Sequence: QIKIWFQNRRK-WKKMVPSDPSYEDMGGC, Genscript, New Jersey) were added to the control medium at concentrations that were based on the literature and summarized in .

Techniques:

Chondrogenic gene expression of ACAN in hBMSCs spheroids after 21 days in culture. No statistically significant differences were observed between groups except for TGF-β3, which had significantly higher aggrecan expression compared to all other groups, including a 10,000-fold larger value compared to the negative control. ∗∗∗∗Refers to significant difference p ​< ​0.0001, n ​= ​6–8. Reported values are mean ​+ ​standard deviation. SM ​= ​SM04690, CK ​= ​CK2.1, CM ​= ​CM10, CM/CK (100/100) ​= ​CM10 at 100 ​μM and CK2.1 and 100 ​nM, CM/CK(100/500) ​= ​CM10 at 100 ​μM and CK2.1 and 500 ​nM, CM/CK (200/100) ​= ​CM10 at 200 ​μM and CK2.1 and 100 ​nM, CM/CK(200/500) ​= ​CM10 at 200 ​μM and CK2.1 and 500 ​nM, CM/KGN (100/1) ​= ​CM10 at 100 ​μM and kartogenin at 1 ​μM, CM/KGN (100/10) ​= ​CM10 at 100 ​μM and kartogenin at 10 ​μM, CK/KGN (100/1) ​= ​CK2.1 ​at 100 ​nM and kartogenin at 1 ​ ​μM, CK/KGN (100/10) ​= ​CK2.1 ​at 100 ​nM and kartogenin at 10 ​μM, CM/SM (100/30) ​= ​CM10 at 100 ​μM and SM04690 at 30 ​nM, CM/SM (100/100) ​= ​CM10 at 100 ​μM and SM04690 at 100 ​nM, CK/SM (100/30) ​= ​CK2.1 at 100 ​nM and SM04690 at 30 ​nM, CK/SM (100/100) ​= ​CK2.1 at 100 ​nM and SM04690 at 100 ​nM.

Journal: Osteoarthritis and Cartilage Open

Article Title: Comparison of multiple synthetic chondroinductive factors in pellet culture against a TGF-β positive control

doi: 10.1016/j.ocarto.2023.100369

Figure Lengend Snippet: Chondrogenic gene expression of ACAN in hBMSCs spheroids after 21 days in culture. No statistically significant differences were observed between groups except for TGF-β3, which had significantly higher aggrecan expression compared to all other groups, including a 10,000-fold larger value compared to the negative control. ∗∗∗∗Refers to significant difference p ​< ​0.0001, n ​= ​6–8. Reported values are mean ​+ ​standard deviation. SM ​= ​SM04690, CK ​= ​CK2.1, CM ​= ​CM10, CM/CK (100/100) ​= ​CM10 at 100 ​μM and CK2.1 and 100 ​nM, CM/CK(100/500) ​= ​CM10 at 100 ​μM and CK2.1 and 500 ​nM, CM/CK (200/100) ​= ​CM10 at 200 ​μM and CK2.1 and 100 ​nM, CM/CK(200/500) ​= ​CM10 at 200 ​μM and CK2.1 and 500 ​nM, CM/KGN (100/1) ​= ​CM10 at 100 ​μM and kartogenin at 1 ​μM, CM/KGN (100/10) ​= ​CM10 at 100 ​μM and kartogenin at 10 ​μM, CK/KGN (100/1) ​= ​CK2.1 ​at 100 ​nM and kartogenin at 1 ​ ​μM, CK/KGN (100/10) ​= ​CK2.1 ​at 100 ​nM and kartogenin at 10 ​μM, CM/SM (100/30) ​= ​CM10 at 100 ​μM and SM04690 at 30 ​nM, CM/SM (100/100) ​= ​CM10 at 100 ​μM and SM04690 at 100 ​nM, CK/SM (100/30) ​= ​CK2.1 at 100 ​nM and SM04690 at 30 ​nM, CK/SM (100/100) ​= ​CK2.1 at 100 ​nM and SM04690 at 100 ​nM.

Article Snippet: For experimental groups, KGN (Cat# HY-16268, MedChemExpress, Monmouth Junction, NJ), SM04690 (Cat# HY-109049, MedChemExpress, Monmouth Junction, NJ), CM10 (Sequence LIANAK, Genscript, New Jersey), and/or CK2.1 (Sequence: QIKIWFQNRRK-WKKMVPSDPSYEDMGGC, Genscript, New Jersey) were added to the control medium at concentrations that were based on the literature and summarized in .

Techniques: Gene Expression, Expressing, Negative Control

Chondrogenic gene expression of SOX-9 in hBMSCs spheroids after 21 days in culture. No significance was observed between groups except for TGF-β3 with a 50-fold higher gene expression as compared to the negative control. ∗∗∗∗Refers to significant difference p ​< ​0.0001, n ​= ​6–8. Reported values are mean ​+ ​standard deviation. SM ​= ​SM04690, CK ​= ​CK2.1, CM ​= ​CM10, CM/CK (100/100) ​= ​CM10 at 100 ​μM and CK2.1 and 100 ​nM, CM/CK(100/500) ​= ​CM10 at 100 ​μM and CK2.1 and 500 ​nM, CM/CK (200/100) ​= ​CM10 at 200 ​μM and CK2.1 and 100 ​nM, CM/CK(200/500) ​= ​CM10 at 200 ​μM and CK2.1 and 500 ​nM, CM/KGN (100/1) ​= ​CM10 at 100 ​μM and kartogenin at 1 ​μM, CM/KGN (100/10) ​= ​CM10 at 100 ​μM and kartogenin at 10 ​μM, CK/KGN (100/1) ​= ​CK2.1 at 100 ​nM and kartogenin at 1 ​ ​μM, CK/KGN (100/10) ​= ​CK2.1 at 100 ​nM and kartogenin at 10 ​μM, CM/SM (100/30) ​= ​CM10 at 100 ​μM and SM04690 at 30 ​nM, CM/SM (100/100) ​= ​CM10 at 100 ​μM and SM04690 at 100 ​nM, CK/SM (100/30) ​= ​CK2.1 at 100 ​nM and SM04690 at 30 ​nM, CK/SM (100/100) ​= ​CK2.1 at 100 ​nM and SM04690 at 100 ​nM.

Journal: Osteoarthritis and Cartilage Open

Article Title: Comparison of multiple synthetic chondroinductive factors in pellet culture against a TGF-β positive control

doi: 10.1016/j.ocarto.2023.100369

Figure Lengend Snippet: Chondrogenic gene expression of SOX-9 in hBMSCs spheroids after 21 days in culture. No significance was observed between groups except for TGF-β3 with a 50-fold higher gene expression as compared to the negative control. ∗∗∗∗Refers to significant difference p ​< ​0.0001, n ​= ​6–8. Reported values are mean ​+ ​standard deviation. SM ​= ​SM04690, CK ​= ​CK2.1, CM ​= ​CM10, CM/CK (100/100) ​= ​CM10 at 100 ​μM and CK2.1 and 100 ​nM, CM/CK(100/500) ​= ​CM10 at 100 ​μM and CK2.1 and 500 ​nM, CM/CK (200/100) ​= ​CM10 at 200 ​μM and CK2.1 and 100 ​nM, CM/CK(200/500) ​= ​CM10 at 200 ​μM and CK2.1 and 500 ​nM, CM/KGN (100/1) ​= ​CM10 at 100 ​μM and kartogenin at 1 ​μM, CM/KGN (100/10) ​= ​CM10 at 100 ​μM and kartogenin at 10 ​μM, CK/KGN (100/1) ​= ​CK2.1 at 100 ​nM and kartogenin at 1 ​ ​μM, CK/KGN (100/10) ​= ​CK2.1 at 100 ​nM and kartogenin at 10 ​μM, CM/SM (100/30) ​= ​CM10 at 100 ​μM and SM04690 at 30 ​nM, CM/SM (100/100) ​= ​CM10 at 100 ​μM and SM04690 at 100 ​nM, CK/SM (100/30) ​= ​CK2.1 at 100 ​nM and SM04690 at 30 ​nM, CK/SM (100/100) ​= ​CK2.1 at 100 ​nM and SM04690 at 100 ​nM.

Article Snippet: For experimental groups, KGN (Cat# HY-16268, MedChemExpress, Monmouth Junction, NJ), SM04690 (Cat# HY-109049, MedChemExpress, Monmouth Junction, NJ), CM10 (Sequence LIANAK, Genscript, New Jersey), and/or CK2.1 (Sequence: QIKIWFQNRRK-WKKMVPSDPSYEDMGGC, Genscript, New Jersey) were added to the control medium at concentrations that were based on the literature and summarized in .

Techniques: Gene Expression, Negative Control

Gene expression of collagen I of hBMSCs spheroids after 21 days in culture. A variation in the gene expression of collagen I by hBMSCs was observed in response to the evaluated compounds and peptides. CM10 (100 ​μM) had the highest gene expression with 2.5-fold higher expression compared to the control group. CK2.1 exhibited higher gene expression of collagen I by 1.8 folds and 1.4 folds at 100 ​nM and 500 ​nM, respectively. The combination of compounds and peptides did not induce a significant difference in collagen I gene expression as compared to the negative control group. Groups with the same letters indicate no significance, n ​= ​6–8. Reported values are mean ​+ ​standard deviation. SM ​= ​SM04690, CK ​= ​CK2.1, CM ​= ​CM10, CM/CK (100/100) ​= ​CM10 at 100 ​μM and CK2.1 and 100 ​nM, CM/CK(100/500) ​= ​CM10 at 100 ​μM and CK2.1 and 500 ​nM, CM/CK (200/100) ​= ​CM10 at 200 ​μM and CK2.1 and 100 ​nM, CM/CK(200/500) ​= ​CM10 at 200 ​μM and CK2.1 and 500 ​nM, CM/KGN (100/1) ​= ​CM10 at 100 ​μM and kartogenin at 1 ​μM, CM/KGN (100/10) ​= ​CM10 at 100 ​μM and kartogenin at 10 ​μM, CK/KGN (100/1) ​= ​CK2.1 at 100 ​nM and kartogenin at 1 ​ ​μM, CK/KGN (100/10) ​= ​CK2.1 at 100 ​nM and kartogenin at 10 ​μM, CM/SM (100/30) ​= ​CM10 at 100 ​μM and SM04690 at 30 ​nM, CM/SM (100/100) ​= ​CM10 at 100 ​μM and SM04690 at 100 ​nM, CK/SM (100/30) ​= ​CK2.1 at 100 ​nM and SM04690 at 30 ​nM, CK/SM (100/100) ​= ​CK2.1 at 100 ​nM and SM04690 at 100 ​nM.

Journal: Osteoarthritis and Cartilage Open

Article Title: Comparison of multiple synthetic chondroinductive factors in pellet culture against a TGF-β positive control

doi: 10.1016/j.ocarto.2023.100369

Figure Lengend Snippet: Gene expression of collagen I of hBMSCs spheroids after 21 days in culture. A variation in the gene expression of collagen I by hBMSCs was observed in response to the evaluated compounds and peptides. CM10 (100 ​μM) had the highest gene expression with 2.5-fold higher expression compared to the control group. CK2.1 exhibited higher gene expression of collagen I by 1.8 folds and 1.4 folds at 100 ​nM and 500 ​nM, respectively. The combination of compounds and peptides did not induce a significant difference in collagen I gene expression as compared to the negative control group. Groups with the same letters indicate no significance, n ​= ​6–8. Reported values are mean ​+ ​standard deviation. SM ​= ​SM04690, CK ​= ​CK2.1, CM ​= ​CM10, CM/CK (100/100) ​= ​CM10 at 100 ​μM and CK2.1 and 100 ​nM, CM/CK(100/500) ​= ​CM10 at 100 ​μM and CK2.1 and 500 ​nM, CM/CK (200/100) ​= ​CM10 at 200 ​μM and CK2.1 and 100 ​nM, CM/CK(200/500) ​= ​CM10 at 200 ​μM and CK2.1 and 500 ​nM, CM/KGN (100/1) ​= ​CM10 at 100 ​μM and kartogenin at 1 ​μM, CM/KGN (100/10) ​= ​CM10 at 100 ​μM and kartogenin at 10 ​μM, CK/KGN (100/1) ​= ​CK2.1 at 100 ​nM and kartogenin at 1 ​ ​μM, CK/KGN (100/10) ​= ​CK2.1 at 100 ​nM and kartogenin at 10 ​μM, CM/SM (100/30) ​= ​CM10 at 100 ​μM and SM04690 at 30 ​nM, CM/SM (100/100) ​= ​CM10 at 100 ​μM and SM04690 at 100 ​nM, CK/SM (100/30) ​= ​CK2.1 at 100 ​nM and SM04690 at 30 ​nM, CK/SM (100/100) ​= ​CK2.1 at 100 ​nM and SM04690 at 100 ​nM.

Article Snippet: For experimental groups, KGN (Cat# HY-16268, MedChemExpress, Monmouth Junction, NJ), SM04690 (Cat# HY-109049, MedChemExpress, Monmouth Junction, NJ), CM10 (Sequence LIANAK, Genscript, New Jersey), and/or CK2.1 (Sequence: QIKIWFQNRRK-WKKMVPSDPSYEDMGGC, Genscript, New Jersey) were added to the control medium at concentrations that were based on the literature and summarized in .

Techniques: Gene Expression, Expressing, Control, Negative Control

Gene expression of ACAN, SOX-9, and collagen I of hBMSCs spheroids from 3 different donors after 21 days in culture. For ACAN, no statistically significant differences were observed between groups except for TGF-β3 with all donors. Donor-based variation in the gene expression of SOX-9 in response to experimental groups was observed. Notably, CM10 had a significantly higher gene expression of SOX-9 as compared to the negative control only with donor 1 (Female, 20 ​yrs). SM04690, CM10, and CK2.1 induced a significantly lower gene expression of collagen I as compared to the negative control with all donors, whereas KGN had variable outcomes based on the donor. Groups with the same letters indicate no significance, n ​= ​6–8. Reported values are mean ​+ ​standard deviation. SM ​= ​SM04690, CK ​= ​CK2.1, CM ​= ​CM10.

Journal: Osteoarthritis and Cartilage Open

Article Title: Comparison of multiple synthetic chondroinductive factors in pellet culture against a TGF-β positive control

doi: 10.1016/j.ocarto.2023.100369

Figure Lengend Snippet: Gene expression of ACAN, SOX-9, and collagen I of hBMSCs spheroids from 3 different donors after 21 days in culture. For ACAN, no statistically significant differences were observed between groups except for TGF-β3 with all donors. Donor-based variation in the gene expression of SOX-9 in response to experimental groups was observed. Notably, CM10 had a significantly higher gene expression of SOX-9 as compared to the negative control only with donor 1 (Female, 20 ​yrs). SM04690, CM10, and CK2.1 induced a significantly lower gene expression of collagen I as compared to the negative control with all donors, whereas KGN had variable outcomes based on the donor. Groups with the same letters indicate no significance, n ​= ​6–8. Reported values are mean ​+ ​standard deviation. SM ​= ​SM04690, CK ​= ​CK2.1, CM ​= ​CM10.

Article Snippet: For experimental groups, KGN (Cat# HY-16268, MedChemExpress, Monmouth Junction, NJ), SM04690 (Cat# HY-109049, MedChemExpress, Monmouth Junction, NJ), CM10 (Sequence LIANAK, Genscript, New Jersey), and/or CK2.1 (Sequence: QIKIWFQNRRK-WKKMVPSDPSYEDMGGC, Genscript, New Jersey) were added to the control medium at concentrations that were based on the literature and summarized in .

Techniques: Gene Expression, Negative Control